Medtronic CEO targets 40% share of patient monitoring market after Covidien deal's close

Medtronic CEO Omar Ishrak tells employees that its pending combination with Covidien lays the table for taking a 40% share of the patient monitoring market.

Covidien, Medtronic

News Well, Medtronic buys Covidien, Mergers & Acquisitions

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qp8L4z